{"id":2014,"date":"2020-09-30T00:25:29","date_gmt":"2020-09-30T00:25:29","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=2014"},"modified":"2023-08-29T18:01:57","modified_gmt":"2023-08-29T18:01:57","slug":"astrazeneca-sources-impedimeds-sozo-devices-upcoming-clinical-trial","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=2014","title":{"rendered":"AstraZeneca\u91c7\u8d2dImpediMed\u7684SOZO\u8bbe\u5907\u7528\u4e8e\u5373\u5c06\u8fdb\u884c\u7684\u4e34\u5e8a\u8bd5\u9a8c"},"content":{"rendered":"<p>\u533b\u7597\u6280\u672f\u516c\u53f8<a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=IPD&amp;lang=cn\">ImpediMed (ASX: IPD)<\/a>\u516c\u5e03\u4e86\u4e00\u4efd\u4ef7\u503c\u8d85\u8fc7200\u4e07\u6fb3\u5143\u7684SOZO\u6570\u5b57\u5065\u5eb7\u5e73\u53f0\u5408\u540c\uff0c\u8fd9\u4e3a\u8be5\u5e73\u53f0\u88ab\u5168\u7403\u751f\u7269\u5236\u836f\u5de8\u5934AstraZeneca\u7528\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\u94fa\u5e73\u4e86\u9053\u8def\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u8868\u793a\uff0c\u5927\u7ea6175\u53f0SOZO\u8bbe\u5907\u5c06\u7528\u4e8e\u4e8c\u671f\u8bd5\u9a8c\uff0c\u4ee5\u8ffd\u8e2a\u5fc3\u810f\u8870\u7aed\u548c\u6162\u6027\u80be\u75c5\u60a3\u8005\u7684\u4f53\u6db2\u91cf\u3002\u8fd9\u9879\u7814\u7a76\u5b9a\u4e8e11\u6708\u5f00\u59cb\uff0c\u9884\u8ba1\u6301\u7eed\u7ea618\u4e2a\u6708\u3002<\/p>\n<p>ImpediMed\u516c\u53f8\u7684SOZO\u5e73\u53f0\u5df2\u7ecf\u901a\u8fc7\u4e86\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u7684\u5fc3\u810f\u8870\u7aed\u8ba4\u8bc1\uff0c\u540c\u65f6\u4e5f\u5728\u6b27\u6d32\u88abce\u6807\u8bb0\u4e3a\u5fc3\u810f\u8870\u7aed\u548c\u80be\u529f\u80fd\u8870\u7aed\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u7684\u751f\u7269\u963b\u6297\u5149\u8c31(BIS)\u8bbe\u5907\u53ef\u4ee5\u65e0\u521b\u4f24\u5730\u6d4b\u91cf\u60a3\u8005\u7684\u5168\u8eab\u6c34\u3001\u7ec6\u80de\u5916\u548c\u7ec6\u80de\u5185\u7684\u6db2\u4f53\u91cf\uff0c\u4ee5\u5e2e\u52a9\u8bc4\u4f30\u548c\u5e72\u9884\u6162\u6027\u75be\u75c5\u3002<\/p>\n<p>\u636eImpediMed\u4ecb\u7ecd\uff0cSOZO\u662f\u4e16\u754c\u4e0a\u6700\u5148\u8fdb\u7684\u975e\u4fb5\u5165\u6027BIS\u8bbe\u5907\uff0c\u5b83\u80fd\u5728\u201c30\u79d2\u5185\u201d\u4e3a\u533b\u7597\u4e13\u4e1a\u4eba\u5458\u63d0\u4f9b\u6d41\u4f53\u72b6\u6001\u548c\u7ec4\u7ec7\u7ec4\u6210\u7684\u7cbe\u786e\u5feb\u7167\u3002<\/p>\n<p>AstraZeneca\u7684\u7814\u7a76\u5c06\u8bc4\u4f30\u4e24\u79cdAstraZeneca\u836f\u7269\u8054\u5408\u6cbb\u7597\u5fc3\u529b\u8870\u7aed\u5408\u5e76\u6162\u6027\u80be\u75c5\u60a3\u8005\u7684\u7597\u6548\u3001\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\u3002\u4e3a\u4e86\u5b8c\u6210\u8fd9\u9879\u7814\u7a76\uff0c\u751f\u7269\u5236\u836f\u5de8\u5934\u9009\u62e9\u4e86SOZO\u4f5c\u4e3a\u9996\u9009\u8bbe\u5907\u4f9b\u5e94\u5546\u3002<\/p>\n<p>\u6839\u636e\u534f\u8bae\u6761\u6b3e\uff0c\u5728\u7814\u7a76\u671f\u95f4\uff0c\u6bcf\u53f0\u8bbe\u5907\u5c06\u6309\u6708\u6536\u53d6\u8bb8\u53ef\u8d39\uff0c\u4f46\u5728\u8bd5\u9a8c\u7ed3\u675f\u540e\uff0c\u8fd9\u4e9b\u8bbe\u5907\u7684\u6240\u6709\u6743\u5c06\u53d7\u5230\u9650\u5236\u3002<\/p>\n<p>\u201cAstraZeneca\u516c\u53f8\u4f7f\u7528ImpediMed\u516c\u53f8\u7684BIS\u6280\u672f\u5728\u4e34\u5e8a\u7814\u7a76\u4e2d\u6d4b\u91cf\u53d7\u8bd5\u8005\u7684\u4f53\u6db2\u91cf\u5df2\u7ecf\u6709\u5f88\u591a\u5e74\u4e86\uff0c\u201dImpediMed\u516c\u53f8\u7684\u9ad8\u7ea7\u526f\u603b\u88c1Dennis Schlaht\u8bf4\u3002<\/p>\n<p>\u6709\u4e86SOZO\uff0c\u4ed6\u4eec\u5c06\u80fd\u591f\u572830\u79d2\u800c\u4e0d\u662f24\u5c0f\u65f6\u7684\u6d4b\u8bd5\u4e2d\u8fbe\u5230\u91d1\u6807\u51c6\u7a00\u91ca\u6cd5\u7684\u6d41\u4f53\u6d4b\u91cf\u7cbe\u5ea6\u3002\u518d\u52a0\u4e0a\u5b83\u63d0\u4f9b\u4e86\u5168\u7403\u8303\u56f4\u5185\u7684\u5b9e\u65f6\u6570\u636e\u5ba1\u67e5\uff0c\u6240\u4ee5\u8fd9\u9879\u65b0\u7814\u7a76\u9009\u62e9SOZO\u6570\u5b57\u5065\u5eb7\u5e73\u53f0\u7684\u539f\u56e0\u5c31\u5f88\u6e05\u695a\u4e86\u3002\u201d<\/p>\n<h2>ImpediMed\u5fc3\u810f\u75c5\u5b66\u53d1\u884c<\/h2>\n<p>\u4f5c\u4e3a\u5c06\u5176\u4ea7\u54c1\u6253\u5165\u5fc3\u810f\u75c5\u5b66\u5e02\u573a\u7684\u603b\u4f53\u8ba1\u5212\u7684\u4e00\u90e8\u5206\uff0cImpediMed\u8868\u793a\uff0c\u5373\u5c06\u5230\u6765\u7684\u8bd5\u9a8c\u5c06\u4e3a\u7f8e\u56fd\u548c\u5168\u7403\u7684\u5927\u91cf\u5fc3\u810f\u75c5\u4e13\u5bb6\u63d0\u4f9b\u4f7f\u7528\u8be5\u8bbe\u5907\u7684\u7b2c\u4e00\u624b\u7ecf\u9a8c\uff0c\u540c\u65f6\u4e5f\u4e0e\u8be5\u516c\u53f8\u8fdb\u5165\u5fc3\u810f\u75c5\u5b66\u5e02\u573a\u7684\u65f6\u95f4\u4e00\u81f4\u3002<\/p>\n<p>\u6700\u65b0\u7814\u7a76\u8868\u660e\uff0c\u5fc3\u8840\u7ba1\u75be\u75c5\u662f\u80be\u75c5\u60a3\u8005\u6b7b\u4ea1\u7684\u9996\u8981\u539f\u56e0\u3002<\/p>\n<p>\u6b64\u5916\uff0c\u7814\u7a76\u4eba\u5458\u53d1\u73b0\uff0c\u5728\u539f\u53d1\u6027\u5fc3\u529b\u8870\u7aed\u4f4f\u9662\u7684\u60a3\u8005\u4e2d\uff0c\u670947%\u7684\u60a3\u8005\u540c\u65f6\u60a3\u6709\u6162\u6027\u80be\u75c5\u3002<\/p>\n<p>\u201c\u5fc3\u529b\u8870\u7aed\u548c\u6162\u6027\u80be\u75c5\u662f\u6211\u4eec\u4e09\u4e2a\u6218\u7565\u91cd\u70b9\u9886\u57df\u4e2d\u7684\u4e24\u4e2a\uff0c\u8fd9\u9879\u534f\u8bae\u8fdb\u4e00\u6b65\u9a8c\u8bc1\u4e86\u6211\u4eec\u7684\u6280\u672f\u5728\u8fd9\u4e24\u4e2a\u60a3\u8005\u7fa4\u4f53\u4e2d\u7684\u9002\u7528\u6027\u3002\u5bf9\u6211\u4eec\u6280\u672f\u7684\u8ba4\u53ef\u662f\u53ca\u65f6\u7684\uff0c\u56e0\u4e3a\u516c\u53f8\u5f00\u59cb\u63a8\u51faSOZO\u8fdb\u5165\u5fc3\u810f\u75c5\u5e02\u573a\uff0c\u201dImpediMed\u8463\u4e8b\u603b\u7ecf\u7406\u517c\u9996\u5e2d\u6267\u884c\u5b98Richard Carreon\u8bf4\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u533b\u7597\u6280\u672f\u516c\u53f8ImpediMed (ASX: IPD)\u516c\u5e03\u4e86\u4e00\u4efd\u4ef7\u503c\u8d85\u8fc7200\u4e07\u6fb3\u5143\u7684SOZO\u6570\u5b57\u5065\u5eb7\u5e73\u53f0\u5408\u540c\uff0c\u8fd9\u4e3a\u8be5\u5e73\u53f0\u88ab\u5168\u7403\u751f\u7269\u5236\u836f\u5de8\u5934AstraZeneca\u7528\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\u94fa\u5e73\u4e86\u9053\u8def\u3002 \u8be5\u516c\u53f8\u8868\u793a\uff0c\u5927\u7ea6175\u53f0SOZO\u8bbe\u5907\u5c06\u7528\u4e8e\u4e8c\u671f\u8bd5\u9a8c\uff0c\u4ee5\u8ffd\u8e2a\u5fc3\u810f\u8870\u7aed\u548c\u6162\u6027\u80be\u75c5\u60a3\u8005\u7684\u4f53\u6db2\u91cf\u3002\u8fd9\u9879\u7814\u7a76\u5b9a\u4e8e11\u6708\u5f00\u59cb\uff0c\u9884\u8ba1\u6301\u7eed\u7ea618\u4e2a\u6708\u3002 ImpediMed\u516c\u53f8\u7684SOZO\u5e73\u53f0\u5df2\u7ecf\u901a\u8fc7\u4e86\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u7684\u5fc3\u810f\u8870\u7aed\u8ba4\u8bc1\uff0c\u540c\u65f6\u4e5f\u5728\u6b27\u6d32\u88abce\u6807\u8bb0\u4e3a\u5fc3\u810f\u8870\u7aed\u548c\u80be\u529f\u80fd\u8870\u7aed\u3002 \u8be5\u516c\u53f8\u7684\u751f\u7269\u963b\u6297\u5149\u8c31(BIS)\u8bbe\u5907\u53ef\u4ee5\u65e0\u521b\u4f24\u5730\u6d4b\u91cf\u60a3\u8005\u7684\u5168\u8eab\u6c34\u3001\u7ec6\u80de\u5916\u548c\u7ec6\u80de\u5185\u7684\u6db2\u4f53\u91cf\uff0c\u4ee5\u5e2e\u52a9\u8bc4\u4f30\u548c\u5e72\u9884\u6162\u6027\u75be\u75c5\u3002 \u636eImpediMed\u4ecb\u7ecd\uff0cSOZO\u662f\u4e16\u754c\u4e0a\u6700\u5148\u8fdb\u7684\u975e\u4fb5\u5165\u6027BIS\u8bbe\u5907\uff0c\u5b83\u80fd\u5728\u201c30\u79d2\u5185\u201d\u4e3a\u533b\u7597\u4e13\u4e1a\u4eba\u5458\u63d0\u4f9b\u6d41\u4f53\u72b6\u6001\u548c\u7ec4\u7ec7\u7ec4\u6210\u7684\u7cbe\u786e\u5feb\u7167\u3002 AstraZeneca\u7684\u7814\u7a76\u5c06\u8bc4\u4f30\u4e24\u79cdAstraZeneca\u836f\u7269\u8054\u5408\u6cbb\u7597\u5fc3\u529b\u8870\u7aed\u5408\u5e76\u6162\u6027\u80be\u75c5\u60a3\u8005\u7684\u7597\u6548\u3001\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\u3002\u4e3a\u4e86\u5b8c\u6210\u8fd9\u9879\u7814\u7a76\uff0c\u751f\u7269\u5236\u836f\u5de8\u5934\u9009\u62e9\u4e86SOZO\u4f5c\u4e3a\u9996\u9009\u8bbe\u5907\u4f9b\u5e94\u5546\u3002 \u6839\u636e\u534f\u8bae\u6761\u6b3e\uff0c\u5728\u7814\u7a76\u671f\u95f4\uff0c\u6bcf\u53f0\u8bbe\u5907\u5c06\u6309\u6708\u6536\u53d6\u8bb8\u53ef\u8d39\uff0c\u4f46\u5728\u8bd5\u9a8c\u7ed3\u675f\u540e\uff0c\u8fd9\u4e9b\u8bbe\u5907\u7684\u6240\u6709\u6743\u5c06\u53d7\u5230\u9650\u5236\u3002 \u201cAstraZeneca\u516c\u53f8\u4f7f\u7528ImpediMed\u516c\u53f8\u7684BIS\u6280\u672f\u5728\u4e34\u5e8a\u7814\u7a76\u4e2d\u6d4b\u91cf\u53d7\u8bd5\u8005\u7684\u4f53\u6db2\u91cf\u5df2\u7ecf\u6709\u5f88\u591a\u5e74\u4e86\uff0c\u201dImpediMed\u516c\u53f8\u7684\u9ad8\u7ea7\u526f\u603b\u88c1Dennis Schlaht\u8bf4\u3002 \u6709\u4e86SOZO\uff0c\u4ed6\u4eec\u5c06\u80fd\u591f\u572830\u79d2\u800c\u4e0d\u662f24\u5c0f\u65f6\u7684\u6d4b\u8bd5\u4e2d\u8fbe\u5230\u91d1\u6807\u51c6\u7a00\u91ca\u6cd5\u7684\u6d41\u4f53\u6d4b\u91cf\u7cbe\u5ea6\u3002\u518d\u52a0\u4e0a\u5b83\u63d0\u4f9b\u4e86\u5168\u7403\u8303\u56f4\u5185\u7684\u5b9e\u65f6\u6570\u636e\u5ba1\u67e5\uff0c\u6240\u4ee5\u8fd9\u9879\u65b0\u7814\u7a76\u9009\u62e9SOZO\u6570\u5b57\u5065\u5eb7\u5e73\u53f0\u7684\u539f\u56e0\u5c31\u5f88\u6e05\u695a\u4e86\u3002\u201d ImpediMed\u5fc3\u810f\u75c5\u5b66\u53d1\u884c \u4f5c\u4e3a\u5c06\u5176\u4ea7\u54c1\u6253\u5165\u5fc3\u810f\u75c5\u5b66\u5e02\u573a\u7684\u603b\u4f53\u8ba1\u5212\u7684\u4e00\u90e8\u5206\uff0cImpediMed\u8868\u793a\uff0c\u5373\u5c06\u5230\u6765\u7684\u8bd5\u9a8c\u5c06\u4e3a\u7f8e\u56fd\u548c\u5168\u7403\u7684\u5927\u91cf\u5fc3\u810f\u75c5\u4e13\u5bb6\u63d0\u4f9b\u4f7f\u7528\u8be5\u8bbe\u5907\u7684\u7b2c\u4e00\u624b\u7ecf\u9a8c\uff0c\u540c\u65f6\u4e5f\u4e0e\u8be5\u516c\u53f8\u8fdb\u5165\u5fc3\u810f\u75c5\u5b66\u5e02\u573a\u7684\u65f6\u95f4\u4e00\u81f4\u3002 \u6700\u65b0\u7814\u7a76\u8868\u660e\uff0c\u5fc3\u8840\u7ba1\u75be\u75c5\u662f\u80be\u75c5\u60a3\u8005\u6b7b\u4ea1\u7684\u9996\u8981\u539f\u56e0\u3002 \u6b64\u5916\uff0c\u7814\u7a76\u4eba\u5458\u53d1\u73b0\uff0c\u5728\u539f\u53d1\u6027\u5fc3\u529b\u8870\u7aed\u4f4f\u9662\u7684\u60a3\u8005\u4e2d\uff0c\u670947%\u7684\u60a3\u8005\u540c\u65f6\u60a3\u6709\u6162\u6027\u80be\u75c5\u3002 \u201c\u5fc3\u529b\u8870\u7aed\u548c\u6162\u6027\u80be\u75c5\u662f\u6211\u4eec\u4e09\u4e2a\u6218\u7565\u91cd\u70b9\u9886\u57df\u4e2d\u7684\u4e24\u4e2a\uff0c\u8fd9\u9879\u534f\u8bae\u8fdb\u4e00\u6b65\u9a8c\u8bc1\u4e86\u6211\u4eec\u7684\u6280\u672f\u5728\u8fd9\u4e24\u4e2a\u60a3\u8005\u7fa4\u4f53\u4e2d\u7684\u9002\u7528\u6027\u3002\u5bf9\u6211\u4eec\u6280\u672f\u7684\u8ba4\u53ef\u662f\u53ca\u65f6\u7684\uff0c\u56e0\u4e3a\u516c\u53f8\u5f00\u59cb\u63a8\u51faSOZO\u8fdb\u5165\u5fc3\u810f\u75c5\u5e02\u573a\uff0c\u201dImpediMed\u8463\u4e8b\u603b\u7ecf\u7406\u517c\u9996\u5e2d\u6267\u884c\u5b98Richard Carreon\u8bf4\u3002<\/p>\n","protected":false},"author":5,"featured_media":9525,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[8],"tags":[618],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>AstraZeneca\u91c7\u8d2dImpediMed\u7684SOZO\u8bbe\u5907\u7528\u4e8e\u5373\u5c06\u8fdb\u884c\u7684\u4e34\u5e8a\u8bd5\u9a8c<\/title>\n<meta name=\"description\" content=\"\u533b\u7597\u6280\u672f\u516c\u53f8ImpediMed (ASX: IPD)\u516c\u5e03\u4e86\u4e00\u4efd\u4ef7\u503c\u8d85\u8fc7200\u4e07\u6fb3\u5143\u7684SOZO\u6570\u5b57\u5065\u5eb7\u5e73\u53f0\u5408\u540c\uff0c\u8fd9\u4e3a\u8be5\u5e73\u53f0\u88ab\u5168\u7403\u751f\u7269\u5236\u836f\u5de8\u5934AstraZeneca\u7528\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\u94fa\u5e73\u4e86\u9053\u8def\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AstraZeneca\u91c7\u8d2dImpediMed\u7684SOZO\u8bbe\u5907\u7528\u4e8e\u5373\u5c06\u8fdb\u884c\u7684\u4e34\u5e8a\u8bd5\u9a8c\" \/>\n<meta property=\"og:description\" content=\"\u533b\u7597\u6280\u672f\u516c\u53f8ImpediMed (ASX: IPD)\u516c\u5e03\u4e86\u4e00\u4efd\u4ef7\u503c\u8d85\u8fc7200\u4e07\u6fb3\u5143\u7684SOZO\u6570\u5b57\u5065\u5eb7\u5e73\u53f0\u5408\u540c\uff0c\u8fd9\u4e3a\u8be5\u5e73\u53f0\u88ab\u5168\u7403\u751f\u7269\u5236\u836f\u5de8\u5934AstraZeneca\u7528\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\u94fa\u5e73\u4e86\u9053\u8def\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/astrazeneca-sources-impedimeds-sozo-devices-upcoming-clinical-trial\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-30T00:25:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:01:57+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/09\/ImpediMed-ASX-IPD-SOZO-AstraZeneca-clinical-trial-fluid-kidney-disease-heart-failure.jpg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"AstraZeneca\u91c7\u8d2dImpediMed\u7684SOZO\u8bbe\u5907\u7528\u4e8e\u5373\u5c06\u8fdb\u884c\u7684\u4e34\u5e8a\u8bd5\u9a8c\" \/>\n<meta name=\"twitter:description\" content=\"\u533b\u7597\u6280\u672f\u516c\u53f8ImpediMed (ASX: IPD)\u516c\u5e03\u4e86\u4e00\u4efd\u4ef7\u503c\u8d85\u8fc7200\u4e07\u6fb3\u5143\u7684SOZO\u6570\u5b57\u5065\u5eb7\u5e73\u53f0\u5408\u540c\uff0c\u8fd9\u4e3a\u8be5\u5e73\u53f0\u88ab\u5168\u7403\u751f\u7269\u5236\u836f\u5de8\u5934AstraZeneca\u7528\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\u94fa\u5e73\u4e86\u9053\u8def\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/09\/ImpediMed-ASX-IPD-SOZO-AstraZeneca-clinical-trial-fluid-kidney-disease-heart-failure.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/astrazeneca-sources-impedimeds-sozo-devices-upcoming-clinical-trial\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/astrazeneca-sources-impedimeds-sozo-devices-upcoming-clinical-trial\/\",\"name\":\"AstraZeneca\u91c7\u8d2dImpediMed\u7684SOZO\u8bbe\u5907\u7528\u4e8e\u5373\u5c06\u8fdb\u884c\u7684\u4e34\u5e8a\u8bd5\u9a8c\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2020-09-30T00:25:29+00:00\",\"dateModified\":\"2023-08-29T18:01:57+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"\u533b\u7597\u6280\u672f\u516c\u53f8ImpediMed (ASX: IPD)\u516c\u5e03\u4e86\u4e00\u4efd\u4ef7\u503c\u8d85\u8fc7200\u4e07\u6fb3\u5143\u7684SOZO\u6570\u5b57\u5065\u5eb7\u5e73\u53f0\u5408\u540c\uff0c\u8fd9\u4e3a\u8be5\u5e73\u53f0\u88ab\u5168\u7403\u751f\u7269\u5236\u836f\u5de8\u5934AstraZeneca\u7528\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\u94fa\u5e73\u4e86\u9053\u8def\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/astrazeneca-sources-impedimeds-sozo-devices-upcoming-clinical-trial\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/astrazeneca-sources-impedimeds-sozo-devices-upcoming-clinical-trial\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/astrazeneca-sources-impedimeds-sozo-devices-upcoming-clinical-trial\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AstraZeneca\u91c7\u8d2dImpediMed\u7684SOZO\u8bbe\u5907\u7528\u4e8e\u5373\u5c06\u8fdb\u884c\u7684\u4e34\u5e8a\u8bd5\u9a8c\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AstraZeneca\u91c7\u8d2dImpediMed\u7684SOZO\u8bbe\u5907\u7528\u4e8e\u5373\u5c06\u8fdb\u884c\u7684\u4e34\u5e8a\u8bd5\u9a8c","description":"\u533b\u7597\u6280\u672f\u516c\u53f8ImpediMed (ASX: IPD)\u516c\u5e03\u4e86\u4e00\u4efd\u4ef7\u503c\u8d85\u8fc7200\u4e07\u6fb3\u5143\u7684SOZO\u6570\u5b57\u5065\u5eb7\u5e73\u53f0\u5408\u540c\uff0c\u8fd9\u4e3a\u8be5\u5e73\u53f0\u88ab\u5168\u7403\u751f\u7269\u5236\u836f\u5de8\u5934AstraZeneca\u7528\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\u94fa\u5e73\u4e86\u9053\u8def\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"AstraZeneca\u91c7\u8d2dImpediMed\u7684SOZO\u8bbe\u5907\u7528\u4e8e\u5373\u5c06\u8fdb\u884c\u7684\u4e34\u5e8a\u8bd5\u9a8c","og_description":"\u533b\u7597\u6280\u672f\u516c\u53f8ImpediMed (ASX: IPD)\u516c\u5e03\u4e86\u4e00\u4efd\u4ef7\u503c\u8d85\u8fc7200\u4e07\u6fb3\u5143\u7684SOZO\u6570\u5b57\u5065\u5eb7\u5e73\u53f0\u5408\u540c\uff0c\u8fd9\u4e3a\u8be5\u5e73\u53f0\u88ab\u5168\u7403\u751f\u7269\u5236\u836f\u5de8\u5934AstraZeneca\u7528\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\u94fa\u5e73\u4e86\u9053\u8def\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/astrazeneca-sources-impedimeds-sozo-devices-upcoming-clinical-trial\/","og_site_name":"smallcapsCN","article_published_time":"2020-09-30T00:25:29+00:00","article_modified_time":"2023-08-29T18:01:57+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/09\/ImpediMed-ASX-IPD-SOZO-AstraZeneca-clinical-trial-fluid-kidney-disease-heart-failure.jpg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_title":"AstraZeneca\u91c7\u8d2dImpediMed\u7684SOZO\u8bbe\u5907\u7528\u4e8e\u5373\u5c06\u8fdb\u884c\u7684\u4e34\u5e8a\u8bd5\u9a8c","twitter_description":"\u533b\u7597\u6280\u672f\u516c\u53f8ImpediMed (ASX: IPD)\u516c\u5e03\u4e86\u4e00\u4efd\u4ef7\u503c\u8d85\u8fc7200\u4e07\u6fb3\u5143\u7684SOZO\u6570\u5b57\u5065\u5eb7\u5e73\u53f0\u5408\u540c\uff0c\u8fd9\u4e3a\u8be5\u5e73\u53f0\u88ab\u5168\u7403\u751f\u7269\u5236\u836f\u5de8\u5934AstraZeneca\u7528\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\u94fa\u5e73\u4e86\u9053\u8def\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/09\/ImpediMed-ASX-IPD-SOZO-AstraZeneca-clinical-trial-fluid-kidney-disease-heart-failure.jpg","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/astrazeneca-sources-impedimeds-sozo-devices-upcoming-clinical-trial\/","url":"https:\/\/smallcapscn.x5view.co\/astrazeneca-sources-impedimeds-sozo-devices-upcoming-clinical-trial\/","name":"AstraZeneca\u91c7\u8d2dImpediMed\u7684SOZO\u8bbe\u5907\u7528\u4e8e\u5373\u5c06\u8fdb\u884c\u7684\u4e34\u5e8a\u8bd5\u9a8c","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2020-09-30T00:25:29+00:00","dateModified":"2023-08-29T18:01:57+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"\u533b\u7597\u6280\u672f\u516c\u53f8ImpediMed (ASX: IPD)\u516c\u5e03\u4e86\u4e00\u4efd\u4ef7\u503c\u8d85\u8fc7200\u4e07\u6fb3\u5143\u7684SOZO\u6570\u5b57\u5065\u5eb7\u5e73\u53f0\u5408\u540c\uff0c\u8fd9\u4e3a\u8be5\u5e73\u53f0\u88ab\u5168\u7403\u751f\u7269\u5236\u836f\u5de8\u5934AstraZeneca\u7528\u4e8e\u4e34\u5e8a\u8bd5\u9a8c\u94fa\u5e73\u4e86\u9053\u8def\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/astrazeneca-sources-impedimeds-sozo-devices-upcoming-clinical-trial\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/astrazeneca-sources-impedimeds-sozo-devices-upcoming-clinical-trial\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/astrazeneca-sources-impedimeds-sozo-devices-upcoming-clinical-trial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"AstraZeneca\u91c7\u8d2dImpediMed\u7684SOZO\u8bbe\u5907\u7528\u4e8e\u5373\u5c06\u8fdb\u884c\u7684\u4e34\u5e8a\u8bd5\u9a8c"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2014"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2014"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2014\/revisions"}],"predecessor-version":[{"id":9524,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2014\/revisions\/9524"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/9525"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}